Watch Corporate Video

R&D Capabilities

  • State-of-the art R&D facility with world-class equipments and helmed by highly skilled scientists- a perfect platform to develop biosimilars with top notch QSE[Quality Safety & Efficacy] profiles.
  • Biosimilars developed following Quality by Design[QbD] based approach to achieve well-characterized process and desired Critical Quality Attributes[CQA].
  • Hetero’s platform technology enables a quick turnaround time for the development of new biosimilars.